Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students

September 5, 2025 updated by: Amber Pearson, Michigan State University

Nature Dose Equity for Students

This project will first examine nature opportunities, belonging and benefits with a multi-state nature-based intervention with a focus on students of color. In light of the syndemic, 'nature deficit disorder' and poor mental health, the investigators anticipate several far-reaching impacts that will (a) test a nationally useful standardized way to quantify exposure; (b) invest in nature resources and accessibility on campuses; and (c) promote the mental health and therapeutic benefits of nature among young adults. These will lead to understanding the nature exposure and mental health interplay and techniques for quantifying and encouraging nature exposure to treat the on-going youth mental health crisis. Including HBCUs and an hispanic-serving institution is expected to result in heightened visibility of underlying disparities, including structural racism and land-based violence and discrimination, that have contributed to current-day nature gaps and dismantled nature relationships for students of color.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

America faces a syndemic of youth 'nature deficit disorder' and poor mental health. These conditions can be improved by nature contact, but the outdoors is not equally accessible, particularly for students of color. This study leverages the NatureDose™ app to identify racial/ethnic inequities in nature opportunities, belonging, and benefits and conduct an RCT to improve mental health and address disparities by getting university students outdoors into nature. The investigators will test 3 over-arching questions:

  1. Are there differences in nature opportunities and/or belongingness for White versus students of color?
  2. Does more time in nature correlate with greater feelings of nature connectedness, belongingness, and better mental health?
  3. Is a nature-based intervention that leverages NatureDoseTM a cost-effective way to improve mental health, particularly for students of color?

This project has two stages. 1) We will determine nature opportunities at each institution using park and sports field mapping, remote sensing, and tree canopy assessment within 30 miles of campuses to identify disparities. 2) As Fall semester starts, we will recruit 160 students/site for a randomized controlled trial (N=1,440 total, giving 80% power to detect effects down to Cohen's d=0.2 even with attrition). Students will complete baseline surveys on nature connectedness (NR-6), nature belongingness (validated scale for university students), mental health (distress, worry, positive/negative affect), and demographics. Next, students will download the NatureDose™ app, which uses 30+ datasets and machine learning models to quantify nature. The app calculates how much nature is near users whenever they are outdoors, and weekly minutes in nature. App data will be collected over a 2-week baseline period, after which students will be randomized to receive 1) standard information about the health benefits of nature (50%) (Active Control) or 2) standard health information, a request to increase weekly minutes in nature, eligibility for a prize, and peer performance comparison. After 2 weeks, students will repeat baseline surveys.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1545

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: Angela M Resseguie, EdD
  • Phone Number: 2313831378
  • Email: ressegu8@msu.edu

Study Locations

  • United States
    • Maryland
      • Baltimore, Maryland, United States, 21251
        • Morgan State University
      • College Park, Maryland, United States, 20742
        • University of Maryland
      • Salisbury, Maryland, United States, 21804
        • University of Maryland Eastern Shore
    • Michigan
      • East Lansing, Michigan, United States, 48824
        • Michigan State University
    • New Mexico
      • Albequerque, New Mexico, United States, 87131
        • University of New Mexico
    • North Carolina
      • Greensboro, North Carolina, United States, 27411
        • North Carolina A&T University
    • Ohio
      • Cleveland, Ohio, United States, 44115
        • Cleveland State University
    • South Carolina
      • Clemson, South Carolina, United States, 29631
        • Clemson University
    • Virginia
      • Charlottesville, Virginia, United States, 22902
        • University of Virginia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Undergraduate student
  • 18-24 years of age
  • Lives within 30 miles of university campus

Exclusion Criteria:

  • Not an undergraduate student
  • Under 18 or over 24 years of age
  • Lives > 30 miles from the university campus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control group receiving standard health information
This group will receive information about health benefits in nature.
Active Comparator: Intervention Group receiving standard health information + incentives to increase time outdoors
This group will receive information on the health benefits of time outdoors, a request to increase their time outdoors, eligibility to receive a prize, and information on peer performance.
Other: Increasing time in nature
This intervention includes requesting an increase in time spent outdoors, eligibility to receive a prize, and information on peer performance.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Kessler-6
Time Frame: From enrollment to end of participation phase, 4 weeks.
Kessler-6 changed to be a two week recall period. Range: 0-24. Higher scores indicate higher distress.
From enrollment to end of participation phase, 4 weeks.
Worry
Time Frame: from enrollment to the final survey (4 week period)
Single question "I worry all the time" on a likert-type scale. Source: https://pubmed.ncbi.nlm.nih.gov/29214862/. Values range from 1-5, whereby a higher score indicates more frequent worry.
from enrollment to the final survey (4 week period)
Positive and Negative Affect Scale
Time Frame: from emrollment to the final survey (4 week period)
This scale is comprised of 20 items, with 10 items measuring positive affect (e.g., excited, inspired) and 10 items measuring negative affect (e.g., upset, afraid). Each item is rated on a five-point Likert Scale, ranging from 1 = Very Slightly or Not at all to 5 = Extremely, to measure the extent to which the affect has been experienced, over a two-week period. Positive affect range: 10-50, whereby higher values indicate higher positive affect. Negative affect range: 10-50, whereby higher values indicate higher negative affect.
from emrollment to the final survey (4 week period)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
NR-6
Time Frame: From enrollment to the final survey (4 week period)
Nature relatedness scale, developed by Nisbet and Zelenski. Each question asked on a likert-type scale from 1 to 5. Then these values are averaged (after considering reverse scored items) to create a score (final score range 1-5), whereby higher values indicate higher nature relatedness.
From enrollment to the final survey (4 week period)
Access to Nature scale
Time Frame: from enrollment to the final survey (4 week period)
Access to nature scale, developed by Anders et al. Source: https://www.sciencedirect.com/science/article/pii/S0272494422001943#appsec1. There twelve questions employ a Likert-type scale where 1 reflected little-to-no barrier and 5 reflected the greatest barrier to access. All items were reverse scored for a total sum that reflected participants' overall access to nature, whereby higher scores indicate fewer barriers to access (range 12-60).
from enrollment to the final survey (4 week period)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Michigan State University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
University of Maryland
Medical College of Wisconsin
University of Virginia
University of New Mexico
Clemson University
Cleveland State University
Morgan State University
University of Maryland Eastern Shore
North Carolina Agricultural and Technical University
REI Cooperative Action Fund

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 9, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 7, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 7, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 9, 2024

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 12, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 5, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • STUDY00010829

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Increasing time in nature

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings